Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Patient satisfaction after endovenous laser treatment for varicose veins

Official title: Patient Satisfaction, Safety and Efficacy of Treatment for Saphenous Veins and Varicose Veins Outside the Operating Theater Under Strict Local Anesthesia With 1940nm Endovenous Laser: a Prospective Multicenter Observational Study

Run by GCS Ramsay Santé pour l'Enseignement et la Recherche · NCT07629843 · Data updated 2026-11-12

This study tests how satisfied patients are after endovenous laser ablation of the saphenous veins when done outside an operating theater under local anesthesia.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment155 (estimated)
SponsorGCS Ramsay Santé pour l'Enseignement et la Recherche
Academic / other
Locations2 sites (Paris and 1 other locations)
StatusRecruiting
StartedOctober 1, 2026
Main results expectedJune 2028
Study endsJune 2028
Registry record updatedOctober 16, 2026
Trial IDNCT07629843 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) undergoing Endovenous Laser Ablation of a primary or recurrent saphenous vein as part of routine care, able to complete questionnaires in French.

Probably not a fit

Patients in whom the procedure is not feasible or who have conditions that exclude participation may not experience benefit from study participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, non-randomized, multicenter observational study to describe patient satisfaction, safety, and outcomes after endovenous laser ablation of the saphenous veins performed under local anesthesia. It includes adult patients receiving routine care for primary or recurrent saphenous vein disease outside the operating theater. Data will be collected from multiple centers in Paris, using the Venous Treatment Satisfaction Questionnaire to gauge patient perspectives, along with safety and efficacy observations. No experimental interventions beyond standard laser treatment are planned, and participants must be able to complete questionnaires in French.

Why it matters

Potential benefit: If successful, the study could provide insight into patient-perceived satisfaction and real-world safety of this treatment approach.

How similar studies have gone: Previous work in similar endovenous laser procedures supports feasibility and positive patient-reported satisfaction in real-world settings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years.
* Endovenous Laser Ablation of a common or recurrent saphenous vein as part of routine care.
* Clinical, Etiology, Anatomy, Pathophysiology, classification clinical stage.
* Ability to understand the study objectives and complete questionnaires in French.
* Patient has been informed and has verbally indicated their non-opposition to participating in the research.

Exclusion Criteria:

* Endovenous Laser Ablation not feasible for technical reasons, particularly if the vein is too "bent" or there are endoluminal obstacles.
* Episode of deep vein thrombosis less than 3 months ago or of superficial vein thrombosis less than 6 weeks ago.
* Active cancer.
* Geographical distance incompatible with study follow-up, according to the investigator's judgment.
* Patients currently participating or having participated in research within the previous 3 months.
* Persons covered by articles L1121-5 to L1121-8 of the French Public Health Code (corresponds to all protected persons: pregnant women, women in labor, breastfeeding mothers, persons deprived of liberty by judicial or administrative decision, persons subject to a legal protection measure).

Where it's running

  • Institut de Pathologie Vasculaire - Hôpital Privé Geoffroy Saint-Hilaire
    Paris, France
    Recruiting
  • Clinique de la Muette
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.